Web Exclusives

Disparities in Cancer Care, Urothelial Cancer
Addressing Health Equity in Bladder Cancer Care
William King
Read More
FDA Approvals
Lonsurf Received a New Indication, in Combination With Bevacizumab, for Previously Treated Metastatic Colorectal Cancer
Read More
FDA Approvals
Jemperli Plus Chemotherapy Now FDA Approved for Front-Line Treatment of dMMR or MSI-H Endometrial Cancer
Read More
In the News
Tornado Sweeps Through Pfizer’s Storage and Manufacturing Facility
Read More
FDA Approvals
Vanflyta Now Approved for Newly Diagnosed FLT3-ITD–Positive AML
Read More
In the News
Acceptance of Artificial Intelligence in Healthcare Is Making Inroads
Read More
Original Research
Cost-Savings Using Patients’ Own Medication Supply of Letermovir for Allogeneic Hematopoietic Stem-Cell Transplant Recipients During Hospitalization
Harrison S. Yoon, PharmD; Mallory Crain, PharmD, BCOP; Marissa Olson, PharmD, BCOP; Anupam Pande, MD, MPH; Jeff O. Klaus, PharmD, BCPS
Read More
Value-Based Care
Survey Shows Inflation Affecting Majority of Consumer Healthcare Decisions
Read More
Original Research, Business
Clinical and Financial Impacts of an Ambulatory Oncology Pharmacist–Based Intravenous Chemotherapy Education and Follow-Up Program
Grant W. Lee, PharmD, BCOP; Joseen J. Chundamala, PharmD; Kerri L. Monahan, PharmD; Judy J. Cho, PharmD; Lydia J. Berry, RPh, PharmD; Christine G. Cambareri, PharmD, BCOP, CSP
Read More
FDA Approvals
Talzenna Received a New Indication, With Enzalutamide, for Metastatic Castration-Resistant Prostate Cancer With HRR Gene Mutation
Read More
Page 2 of 34
Results 11 - 20 of 340
SUBSCRIBE
© Amplity Health. All rights reserved.